Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Reinus

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Annals of Internal Medicine|December 1, 1992
Failure to detect vertical transmission of hepatitis C virusJ F Reinus, E L Leikin, H J Alter, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2007
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis CC L Raison, B J Woolwine, M F Demetrashvili, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' replyK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevirK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Annals of Internal Medicine|December 1, 1992
Failure to detect vertical transmission of hepatitis C virusJ F Reinus, E L Leikin, H J Alter, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2007
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis CC L Raison, B J Woolwine, M F Demetrashvili, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' replyK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevirK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Pageof 3